DE2161344C3 - Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend - Google Patents
Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltendInfo
- Publication number
- DE2161344C3 DE2161344C3 DE2161344A DE2161344A DE2161344C3 DE 2161344 C3 DE2161344 C3 DE 2161344C3 DE 2161344 A DE2161344 A DE 2161344A DE 2161344 A DE2161344 A DE 2161344A DE 2161344 C3 DE2161344 C3 DE 2161344C3
- Authority
- DE
- Germany
- Prior art keywords
- virus
- animals
- viral
- treatment
- prophylaxis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000700605 Viruses Species 0.000 title claims description 42
- 241001465754 Metazoa Species 0.000 title claims description 10
- 239000003814 drug Substances 0.000 title claims description 8
- 238000011282 treatment Methods 0.000 title claims description 8
- 208000036142 Viral infection Diseases 0.000 title claims description 6
- 238000011321 prophylaxis Methods 0.000 title claims description 5
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 230000003612 virological effect Effects 0.000 title claims description 4
- 208000035143 Bacterial infection Diseases 0.000 title claims description 3
- 208000022362 bacterial infectious disease Diseases 0.000 title claims description 3
- 230000007246 mechanism Effects 0.000 title claims description 3
- 230000037125 natural defense Effects 0.000 title claims description 3
- 230000000890 antigenic effect Effects 0.000 title description 4
- 102000014150 Interferons Human genes 0.000 claims description 12
- 108010050904 Interferons Proteins 0.000 claims description 12
- 229940079322 interferon Drugs 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 230000028993 immune response Effects 0.000 claims description 6
- 230000006698 induction Effects 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 238000007796 conventional method Methods 0.000 claims 1
- 238000010998 test method Methods 0.000 claims 1
- 230000002238 attenuated effect Effects 0.000 description 15
- 210000002966 serum Anatomy 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000008260 defense mechanism Effects 0.000 description 4
- 206010022000 influenza Diseases 0.000 description 4
- -1 polyoxyethylene Polymers 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000002255 vaccination Methods 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- 230000009385 viral infection Effects 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000004520 agglutination Effects 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 244000144980 herd Species 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 230000037029 cross reaction Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 240000002470 Amphicarpaea bracteata Species 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000539677 Berant virus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010048461 Genital infection Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001500351 Influenzavirus A Species 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 244000243234 giant cane Species 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16732—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
- C12N2710/16764—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (25)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE792484D BE792484A (fr) | 1971-12-10 | Procede de production de souches de virus qui stimulent les mecanismes naturels de defence de l'organisme hote sans produire d'effet antigenique simultane | |
| DE2161344A DE2161344C3 (de) | 1971-12-10 | 1971-12-10 | Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend |
| AR245553A AR204075A1 (es) | 1971-12-10 | 1972-01-01 | Procedimiento para la produccion de una vacuna de virus atenuados que estimula los mecanismos naturales de defensa de un organismo hospedador sin ejercer simultaneamente una accion de antigeno |
| PH14135A PH12597A (en) | 1971-12-10 | 1972-12-01 | Attenuated viral strain and compositions containing the same |
| SU1853618A SU439956A3 (ru) | 1971-12-10 | 1972-12-02 | Способ получения штаммов вирусов для стимуляции интерфероногенеза |
| JP47121265A JPS6011013B2 (ja) | 1971-12-10 | 1972-12-05 | 動物用薬剤 |
| JP47121264A JPS5924137B2 (ja) | 1971-12-10 | 1972-12-05 | 弱毒ウイルスの製造方法 |
| BG022052A BG21417A3 (bg) | 1971-12-10 | 1972-12-06 | Метод за получаване на вирусни щамове,които стимулират естествения отбранителен механизъм на организъм-домакин същевременно свободни от антигенно действие |
| NLAANVRAGE7216628,A NL178014C (nl) | 1971-12-10 | 1972-12-07 | Werkwijze voor het behandelen van virusstammen alsmede werkwijze voor het bereiden van preparaten voor de profylaxe en behandeling van virale en bacteriele infecties bij mens en dier op basis van dergelijke behandelde virusstammen. |
| CS728391A CS189587B2 (en) | 1971-12-10 | 1972-12-07 | Method of preparing viruses strains which stimulate natural defensive ability of microorganisms without contemporary action as antigen |
| AT1041972A AT326817B (de) | 1971-12-10 | 1972-12-07 | Verfahren zur herstellung von virusstämmen |
| ZA728709A ZA728709B (en) | 1971-12-10 | 1972-12-08 | Improvements in and relating to attenuated viruses |
| CH1791372A CH577558A5 (enExample) | 1971-12-10 | 1972-12-08 | |
| DD167455A DD108115A5 (enExample) | 1971-12-10 | 1972-12-08 | |
| HUBA2833A HU167086B (enExample) | 1971-12-10 | 1972-12-08 | |
| DK615472A DK143201C (da) | 1971-12-10 | 1972-12-08 | Fremgangsmaade til fremstilling af virusstammer,som stimulereren vaertsorganismes naturlige afvaergemekanismer uden derved samtidig at virke antigent |
| FR7243868A FR2162637B1 (enExample) | 1971-12-10 | 1972-12-08 | |
| CA158,535A CA988848A (en) | 1971-12-10 | 1972-12-08 | Production of attenuated viruses |
| GB5672372A GB1356076A (en) | 1971-12-10 | 1972-12-08 | Attenuated viruses |
| IE1716/72A IE36995B1 (en) | 1971-12-10 | 1972-12-08 | Improvements in and relating to attenuated viruses |
| ES409464A ES409464A1 (es) | 1971-12-10 | 1972-12-09 | Procedimiento para la produccion de cepas de virus. |
| AU49920/72A AU473209B2 (en) | 1971-12-10 | 1972-12-11 | Improvements in and relating to attenuated viruses |
| US05/482,619 US4017359A (en) | 1971-12-10 | 1974-06-24 | Production of non-antigenic attenuated viruses |
| US05/544,886 US4039656A (en) | 1971-12-10 | 1975-01-29 | Production of attenuated viruses |
| SE8400283A SE8400283L (sv) | 1971-12-10 | 1984-01-20 | Sett att framstella virusstammar som stimulerer en verdorganisms naturliga forsvarsmekanism utan att samtidigt verka antigent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2161344A DE2161344C3 (de) | 1971-12-10 | 1971-12-10 | Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2161344A1 DE2161344A1 (de) | 1973-06-20 |
| DE2161344B2 DE2161344B2 (de) | 1980-05-08 |
| DE2161344C3 true DE2161344C3 (de) | 1986-10-02 |
Family
ID=5827622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2161344A Expired DE2161344C3 (de) | 1971-12-10 | 1971-12-10 | Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend |
Country Status (22)
| Country | Link |
|---|---|
| JP (2) | JPS5924137B2 (enExample) |
| AR (1) | AR204075A1 (enExample) |
| AT (1) | AT326817B (enExample) |
| AU (1) | AU473209B2 (enExample) |
| BE (1) | BE792484A (enExample) |
| BG (1) | BG21417A3 (enExample) |
| CA (1) | CA988848A (enExample) |
| CH (1) | CH577558A5 (enExample) |
| CS (1) | CS189587B2 (enExample) |
| DD (1) | DD108115A5 (enExample) |
| DE (1) | DE2161344C3 (enExample) |
| DK (1) | DK143201C (enExample) |
| ES (1) | ES409464A1 (enExample) |
| FR (1) | FR2162637B1 (enExample) |
| GB (1) | GB1356076A (enExample) |
| HU (1) | HU167086B (enExample) |
| IE (1) | IE36995B1 (enExample) |
| NL (1) | NL178014C (enExample) |
| PH (1) | PH12597A (enExample) |
| SE (1) | SE8400283L (enExample) |
| SU (1) | SU439956A3 (enExample) |
| ZA (1) | ZA728709B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0063657A1 (en) * | 1981-04-29 | 1982-11-03 | Merck & Co. Inc. | Topical application of interferon inducers |
-
0
- BE BE792484D patent/BE792484A/xx not_active IP Right Cessation
-
1971
- 1971-12-10 DE DE2161344A patent/DE2161344C3/de not_active Expired
-
1972
- 1972-01-01 AR AR245553A patent/AR204075A1/es active
- 1972-12-01 PH PH14135A patent/PH12597A/en unknown
- 1972-12-02 SU SU1853618A patent/SU439956A3/ru active
- 1972-12-05 JP JP47121264A patent/JPS5924137B2/ja not_active Expired
- 1972-12-05 JP JP47121265A patent/JPS6011013B2/ja not_active Expired
- 1972-12-06 BG BG022052A patent/BG21417A3/xx unknown
- 1972-12-07 CS CS728391A patent/CS189587B2/cs unknown
- 1972-12-07 NL NLAANVRAGE7216628,A patent/NL178014C/xx not_active IP Right Cessation
- 1972-12-07 AT AT1041972A patent/AT326817B/de not_active IP Right Cessation
- 1972-12-08 GB GB5672372A patent/GB1356076A/en not_active Expired
- 1972-12-08 DD DD167455A patent/DD108115A5/xx unknown
- 1972-12-08 HU HUBA2833A patent/HU167086B/hu unknown
- 1972-12-08 FR FR7243868A patent/FR2162637B1/fr not_active Expired
- 1972-12-08 DK DK615472A patent/DK143201C/da not_active IP Right Cessation
- 1972-12-08 IE IE1716/72A patent/IE36995B1/xx unknown
- 1972-12-08 ZA ZA728709A patent/ZA728709B/xx unknown
- 1972-12-08 CA CA158,535A patent/CA988848A/en not_active Expired
- 1972-12-08 CH CH1791372A patent/CH577558A5/xx not_active IP Right Cessation
- 1972-12-09 ES ES409464A patent/ES409464A1/es not_active Expired
- 1972-12-11 AU AU49920/72A patent/AU473209B2/en not_active Expired
-
1984
- 1984-01-20 SE SE8400283A patent/SE8400283L/sv not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68911019T2 (de) | Kombiniertes Hepatitis A- und B-Vakzin mit Adjuvans. | |
| EP1144001B1 (de) | Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation | |
| DE3789239T2 (de) | Pharmazeutische Zusammensetzung enthaltend Interferon für bukkale Verabreichung. | |
| DE69529224T2 (de) | IMPFSTOFF-ZUSAMMENSETZUNGEN enthaltend teil-deacetyliertes Chitin | |
| DE3911442A1 (de) | Impfstoff-praeparation | |
| EP0304786A2 (de) | Intranasale Impfung von Pferden mit inaktivierten Mikroorganismen oder antigenem Material | |
| DE69432929T2 (de) | Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit | |
| DE2717919A1 (de) | Verfahren zur herstellung eines pferde-rhinopneumonievakzins und durch dieses verfahren hergestelltes vakzin | |
| DE3600083C2 (de) | Verwendung von alpha-Interferon zur Behandlung des respiratorischen Erkrankungskomplexes bei Rindern | |
| DE69633233T2 (de) | Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus | |
| DE2323847C3 (de) | Lebendimpfstoff zur Immunisierung von Rindern gegen die Parainfluenza-3-Virus-Infektion | |
| DE2161344C3 (de) | Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend | |
| DE2620649C3 (de) | Immunologisches Adjuvans | |
| DE3504940C2 (de) | Multipotente Paramunitätsmediatoren, Verfahren zu ihrer Herstellung und diese Mediatoren enthaltende Arzneimittel | |
| DE1924304B2 (de) | Diäthylaminoäthyldextran (DEAE-D) als Adjuvans für Impfstoffe zur aktiven Immunisierung von Säugetieren | |
| DE69028520T2 (de) | Arzneimittelzubereitung bei der behandlung von tonsillitis | |
| US4049794A (en) | Treatment of infections in animals | |
| US4039656A (en) | Production of attenuated viruses | |
| DE1950774A1 (de) | Heteroploide Zellinien | |
| EP0271447B1 (de) | Vorbeugende Massnahmen zur Verhinderung der "Komplexen Respiratorischen Erkrankung bei Rindern" durch Verabreichung von Interferon | |
| DE2225548C3 (de) | Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis | |
| DE69232962T2 (de) | Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält | |
| US4017359A (en) | Production of non-antigenic attenuated viruses | |
| DE69208854T2 (de) | Impfstoff-Zubereitung zur Vorbeugung gegen bei Tieren durch Chlamydia psitacci verursachte Fehlgeburt | |
| CH660125A5 (de) | Gereinigtes, entgiftetes endotoxin enthaltende zusammensetzung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8281 | Inventor (new situation) |
Free format text: STRAUB, OTTO-CHRISTIAN, DR., 7400 TUEBINGEN, DE |
|
| C3 | Grant after two publication steps (3rd publication) |